Expanded Access Guidance On COVID-19 Will Inform US FDA’s Post-Pandemic Policies

 
• By Sue Sutter
Stand out of a crowd - individuality
US FDA is giving advice to IRBs on how to handle individual patient expanded access requests. • Source: Shutterstock

More from Clinical Trials

More from R&D